首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Therapeutic Advances In Musculoskeletal Disease

Therapeutic Advances In Musculoskeletal Disease杂志,由SAGE Publications Inc.出版,于2009年创刊,1 issue/year,出版语言English,ISSN:1759-720X,E-ISSN:1759-7218。

投稿咨询
Therapeutic Advances In Musculoskeletal Disease
Therapeutic Advances In Musculoskeletal Disease
Therapeutic Advances In Musculoskeletal Disease
SCI SCIE

杂志介绍

JCR分区
Q2
中科院分区
2区
影响因子
3.3
CiteScore
7.8
期刊收录
SCI、SCIE

Therapeutic Advances In Musculoskeletal Disease(中文译名:《肌肉骨骼疾病的治疗进展》),ISSN:1759-720X,EISSN:1759-7218,是SAGE Publications Inc.出版的国际性学术期刊,创刊于2009年,以1 issue/year形式稳定发行,2026年总发文量约46篇。该刊采用非OA开放访问,学科归属为Medicine - Rheumatology。该刊是医学、风湿病学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达3.3,2025年期刊CiteScore为7.8,2025年期刊自引率约3%,在中科院期刊分区体系中位列医学大类2区,在所属学科领域具备高学术影响力与国际认可度。Therapeutic Advances In Musculoskeletal Disease长期聚焦医学、风湿病学及相关产业的技术应用前沿,平均审稿周期18 Weeks,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、风湿病学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USAEngland、Italy、CHINA MAINLAND、France、Canada、GERMANY (FED REP GER)等为核心发文国家与地区;UNIVERSITY OF ALABAMA SYSTEMASSISTANCE PUBLIQUE HOPITAUX PARIS (APHP)、FREE UNIVERSITY OF BERLIN、HUMBOLDT UNIVERSITY OF BERLIN、INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)、NATIONAL & KAPODISTRIAN UNIVERSITY OF ATHENS、UNIVERSITY OF GLASGOW等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
RHEUMATOLOGY 风湿病学
2区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
RHEUMATOLOGY 风湿病学
4区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
RHEUMATOLOGY 风湿病学
3区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:RHEUMATOLOGY SCIE Q2 20 / 58

66.4

学科:RHEUMATOLOGY SCIE Q2 23 / 58

61.21

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:RHEUMATOLOGY SCIE Q2 17 / 57

71.1

学科:RHEUMATOLOGY SCIE Q2 22 / 57

62.28


中国学者近期发文

1
Effects of achieving simple disease activity index remission on joint space outcomes progression in early rheumatoid arthritis: an exploratory study using high-resolution peripheral quantitative computed tomograph

Author:Wu, Qihan; So, Ho; Cheng, Isaac T.; Jin, Yingzhao; Lau, Sze-Lok; Chan, Tin-Yuet; Chow, Evelyn; Qin, Ling; Hung, Vivian W.; Griffith, James F; Kwok, Kitty; Yim, Isaac; Ying, Shirley; Lee, Ka Lai Violet; Lee, Jack J. W.; Tam, Lai-Shan

Journal: THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE. 2026; Vol. 18, Issue , pp. -. DOI: 10.1177/1759720X261439714

2
Malignancy risk in patients with rheumatoid arthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: a 5-year population-based cohort stud

Author:Kao, Chung-Mao; Shih, Po-Cheng; Chen, Der-Yuan; Chen, Hsin-Hua

Journal: THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE. 2026; Vol. 18, Issue , pp. -. DOI: 10.1177/1759720X261423830

3
Tracking global quality of life trajectories in knee osteoarthritis: a population-based long-term analysi

Author:Fu, Fanyu; Dong, Li; Lian, Jiwei; Liu, Chang; Pang, Tingting; Wang, Yunli; Liu, Peng; Wang, Yufeng

Journal: THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE. 2026; Vol. 18, Issue , pp. -. DOI: 10.1177/1759720X261426247

4
The association between glucagon-like peptide-1 receptor agonists and reported musculoskeletal adverse events: a systematic review and meta-analysis of randomized controlled trial

Author:Cao, Meng; Lin, Chu; Cai, Xiaoling; Lv, Fang; Yang, Wenjia; Ji, Linong

Journal: THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE. 2026; Vol. 18, Issue , pp. -. DOI: 10.1177/1759720X261428147

5
Association between immune-inflammation index and the risk of gout attack: a systematic review and meta-analysi

Author:Guan, Zhiwei; Zhang, Minjun; Yuan, Ye

Journal: THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE. 2026; Vol. 18, Issue , pp. -. DOI: 10.1177/1759720X251414413

6
Investigating the relationship between osteoporosis and rheumatoid arthritis: prospective cohort study and genetic analyse

Author:Qiu, Lingli; Zhang, Wenqiang; Tan, Zhixin; Wu, Xuan; Wang, Yutong; Tang, Mingshuang; Chen, Lin; Zou, Yanqiu; Liu, Yunjie; Lei, Bowen; Ma, Xiaofeng; Zhang, Di; Wang, Wenzhi; Jia, Yiping; He, Qiurong; Sun, Lei; Wang, Lu; Xu, Jian; Chen, Yao; Fan, Mengyu; Li, Jiayuan; Zhang, Ben; Wen, Xiaoling; Jiang, Xia

Journal: THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE. 2026; Vol. 18, Issue , pp. -. DOI: 10.1177/1759720X251412846

7
The causal relationship between cathepsins and ankylosing spondylitis: a two-sample Mendelian randomization stud

Author:Wu, Baofeng; Li, Ru; Li, Jian; An, Qin; Jin, Shuqing; Liu, Qinhao; Zhang, Yi; Liu, Yunfeng

Journal: THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE. 2026; Vol. 18, Issue , pp. -. DOI: 10.1177/1759720X251408873

8
Associations of blood cell indices with the severity of rheumatoid arthritis: a retrospective case-control and machine learning modeling stud

Author:He, Rongqing; Qin, Boli; Qin, Xiaopeng; Chen, Jiarui; Xue, Jiang; Chen, Tianyou; Wu, Songze; Chen, Zhuo; Zhan, Xinli; Liu, Chong

Journal: THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE. 2026; Vol. 18, Issue , pp. -. DOI: 10.1177/1759720X251407065

9
High-dose folic acid supplement is associated with increased cardiovascular risk in rheumatoid arthritis patients on methotrexat

Author:Meng, Huan; So, Ho; Yan, Xianfeng; Jin, Yingzhao; Lam, Steven H.; Kwok, Timothy; Tam, Lai-Shan

Journal: THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE. 2026; Vol. 18, Issue , pp. -. DOI: 10.1177/1759720X261423837

10
The neutrophil-to-lymphocyte ratio as a surrogate marker for disease activity in systemic lupus erythematosus: a correlation study using the SLE-DA

Author:Wong, Mandy Ming Yan; Lam, Fung; Mok, Chi Chiu

Journal: THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE. 2025; Vol. 17, Issue , pp. -. DOI: 10.1177/1759720X251347272


在线咨询

Therapeutic Advances In Musculoskeletal Disease

国际简称:THER ADV MUSCULOSKEL参考译名:肌肉骨骼疾病的治疗进展

年发文量:46 CiteScore:7.8 是否预警:否 Gold OA文章占比:99.34% 研究类文章占比:73.91%

杂志社联系方式:1 OLIVERS YARD, 55 CITY ROAD, LONDON, ENGLAND, EC1Y 1SP

Therapeutic Advances In Musculoskeletal Disease